Martingale Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.14M | Buy |
|
|||||
|
2025
Q2 | $1.49M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $248K | Sell |
|
|||||
|
2023
Q1 | $195K | Sell |
|
|||||
|
2022
Q4 | $165K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $220K | Sell |
|
|||||
|
2016
Q2 | $570K | Sell |
|
|||||
|
2016
Q1 | $514K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $207K | Buy |
|